Oral Proteins And Peptides Global Market Report 2024

Description

Oral Proteins and Peptides refer to therapeutic proteins and peptides administered orally, typically in pills, capsules, or other ingestible formats. These biologically active molecules are designed to treat various medical conditions by leveraging their specific actions within the body.

The main drug types of oral proteins and peptides are linaclotide, calcitonin, insulin, plecanatide, and octreotide. The biological targets are guanylate cyclase-c (gc-c), insulin receptor, oxalate, and others, and the different mechanisms of action are receptor stimulation, substrate degradation, and others. It is used for various applications such as gastrointestinal disorders, bone disease, neurological disorders, diabetes, metabolic disorders, hormonal disorders, and cancer.

The oral proteins and peptides market research report is one of a series of new reports from The Business Research Company that provides oral proteins and peptides market statistics, including oral proteins and peptides industry global market size, regional shares, competitors with a oral proteins and peptides market share, detailed oral proteins and peptides market segments, market trends and opportunities, and any further data you may need to thrive in the oral proteins and peptides industry. This oral proteins and peptides market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The oral proteins and peptides market size has grown exponentially in recent years. It will grow from $1.04 billion in 2023 to $1.27 billion in 2024 at a compound annual growth rate (CAGR) of 22.1%. The growth during the historical period can be attributed to the increasing prevalence of chronic diseases, heightened investments in biotechnology for developing oral protein-based treatments, a growing consumer preference for non-invasive therapies, expansion within the biopharmaceutical industry, and a rising emphasis on personalized medicine.

The oral proteins and peptides market size is expected to see exponential growth in the next few years. It will grow to $2.86 billion in 2028 at a compound annual growth rate (CAGR) of 22.4%. The growth during the forecast period can be attributed to a greater emphasis on patient-centric drugs, a rising geriatric population, increased healthcare spending, a growing need for cancer diagnostics, and a higher preference for oral medications. Key trends expected during this period include the development of new oral peptides with improved stability and efficacy, the integration of artificial intelligence in drug discovery for oral formulations, advancements in medical treatments, innovations in drug delivery technologies, and novel oral insulin formulations.

The expanding biopharmaceutical industry is expected to drive the growth of the oral proteins and peptides market in the future. This sector, part of the broader pharmaceutical industry, focuses on developing, producing, and commercializing drugs derived from biological sources. The growth of the biopharmaceutical industry is fueled by advancements in biotechnology, increased demand for personalized medicine, a rise in chronic diseases, and higher investment in research and development. Oral proteins and peptides offer the potential for non-invasive therapeutic delivery, improving patient compliance and reducing the need for injections. They can target specific diseases with enhanced stability and absorption in the digestive system. For example, in June 2023, the European Federation of Pharmaceutical Industries and Associations (EFPIA) reported that total biopharmaceutical production in Europe reached $384.2 billion (€340 billion) in 2022, a rise of about 4.95% from $366.3 billion (€323.95 billion) in 2021. Thus, the growth of the biopharmaceutical industry is contributing to the expansion of the oral proteins and peptides market.

Key companies in the oral proteins and peptides market are focusing on developing innovative products such as Oral Semaglutide to improve patient adherence and comfort. Oral Semaglutide represents a significant advancement in the field of oral proteins and peptides. As a glucagon-like peptide-1 (GLP-1) receptor agonist, semaglutide was traditionally administered via injection for the treatment of type 2 diabetes and, more recently, obesity. For example, in January 2022, Novo Nordisk India, a healthcare company based in India, introduced the world's first oral semaglutide, marking a major breakthrough in diabetes treatment. Previously available only in injectable form, this GLP-1 receptor analogue now offers a more convenient oral option for managing type 2 diabetes. This development not only revolutionizes diabetes care but also paves the way for future innovations in oral insulin formulations, potentially leading to more effective and patient-friendly treatment options.

In April 2023, Chiesi Farmaceutici S.p.a., an Italy-based pharmaceutical company, acquired Amryt Pharma Plc for an undisclosed sum. This acquisition allows Chiesi to leverage Amryt's unique products and promising pipeline, bolstering its commitment to rare diseases and expanding its biopharmaceutical expertise. Amryt Pharma Plc, based in the UK, specializes in oral proteins and peptides.

Major companies operating in the oral proteins and peptides market are Pfizer Inc., Johnson & Johnson Services Inc., Roche Holding AG, Merck & Co. Inc., AbbVie Inc., Sanofi S.A., AstraZeneca PLC, Novartis AG, GlaxoSmithKline PLC, Eli Lilly and Company, Amgen Inc., Novo Nordisk A/S, Ipsen S.A., Biocon Limited, Xeris Pharmaceuticals Inc., Adocia S.A., Zealand Pharma A/S, Diabetology Ltd., Oramed Pharmaceuticals Inc., Palatin Technologies Inc., Entera Bio Ltd.

North America was the largest region in the oral proteins and peptides market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the oral proteins and peptides market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the oral proteins and peptides market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The oral proteins and peptides market consists of sales of protein supplements, peptide-based drugs, and therapeutic formulations designed for oral administration. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Oral Proteins And Peptides Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on oral proteins and peptides market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
Measure the impact of high global inflation on market growth.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for oral proteins and peptides ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The oral proteins and peptides market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Drug Type: Linaclotide; Calcitonin; Insulin; Plecanatide; Octreotide
2) By Biological Target: Guanylate Cyclase-C (GC-C); Insulin Receptor; Oxalate; Other Biological Targets
3) By Mechanism Of Action: Receptor Stimulation; Substrate Degradation; Other Mechanisms Of Action
4) By Application: Gastrointestinal Disorders; Bone Disease; Neurological Disorders; Diabetes; Metabolic Disorders; Hormonal Disorder; Cancer
Companies Mentioned: Pfizer Inc.; Johnson & Johnson Services Inc.; Roche Holding AG; Merck & Co. Inc.; AbbVie Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r20784

1. Executive Summary

2. Oral Proteins And Peptides Market Characteristics

3. Oral Proteins And Peptides Market Trends And Strategies

4. Oral Proteins And Peptides Market - Macro Economic Scenario

4.1. Impact Of High Inflation On The Market
4.2. Ukraine-Russia War Impact On The Market
4.3. COVID-19 Impact On The Market

5. Global Oral Proteins And Peptides Market Size and Growth

5.1. Global Oral Proteins And Peptides Market Drivers and Restraints
- 5.1.1. Drivers Of The Market
- 5.1.2. Restraints Of The Market
5.2. Global Oral Proteins And Peptides Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
5.3. Global Oral Proteins And Peptides Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Oral Proteins And Peptides Market Segmentation

6.1. Global Oral Proteins And Peptides Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Linaclotide
Calcitonin
Insulin
Plecanatide
Octreotide
6.2. Global Oral Proteins And Peptides Market, Segmentation By Biological Target, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Guanylate Cyclase-C (GC-C)
Insulin Receptor
Oxalate
Other Biological Targets
6.3. Global Oral Proteins And Peptides Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Receptor Stimulation
Substrate Degradation
Other Mechanisms Of Action
6.4. Global Oral Proteins And Peptides Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Gastrointestinal Disorders
Bone Disease
Neurological Disorders
Diabetes
Metabolic Disorders
Hormonal Disorder
Cancer

7. Oral Proteins And Peptides Market Regional And Country Analysis

7.1. Global Oral Proteins And Peptides Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
7.2. Global Oral Proteins And Peptides Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Oral Proteins And Peptides Market

8.1. Asia-Pacific Oral Proteins And Peptides Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Oral Proteins And Peptides Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.3. Asia-Pacific Oral Proteins And Peptides Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.4. Asia-Pacific Oral Proteins And Peptides Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Oral Proteins And Peptides Market

9.1. China Oral Proteins And Peptides Market Overview
9.2. China Oral Proteins And Peptides Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.3. China Oral Proteins And Peptides Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.4. China Oral Proteins And Peptides Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Oral Proteins And Peptides Market

10.1. India Oral Proteins And Peptides Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.2. India Oral Proteins And Peptides Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.3. India Oral Proteins And Peptides Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Oral Proteins And Peptides Market

11.1. Japan Oral Proteins And Peptides Market Overview
11.2. Japan Oral Proteins And Peptides Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.3. Japan Oral Proteins And Peptides Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.4. Japan Oral Proteins And Peptides Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Oral Proteins And Peptides Market

12.1. Australia Oral Proteins And Peptides Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.2. Australia Oral Proteins And Peptides Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.3. Australia Oral Proteins And Peptides Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Oral Proteins And Peptides Market

13.1. Indonesia Oral Proteins And Peptides Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.2. Indonesia Oral Proteins And Peptides Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.3. Indonesia Oral Proteins And Peptides Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Oral Proteins And Peptides Market

14.1. South Korea Oral Proteins And Peptides Market Overview
14.2. South Korea Oral Proteins And Peptides Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.3. South Korea Oral Proteins And Peptides Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.4. South Korea Oral Proteins And Peptides Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Oral Proteins And Peptides Market

15.1. Western Europe Oral Proteins And Peptides Market Overview
15.2. Western Europe Oral Proteins And Peptides Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.3. Western Europe Oral Proteins And Peptides Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.4. Western Europe Oral Proteins And Peptides Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Oral Proteins And Peptides Market

16.1. UK Oral Proteins And Peptides Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.2. UK Oral Proteins And Peptides Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.3. UK Oral Proteins And Peptides Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Oral Proteins And Peptides Market

17.1. Germany Oral Proteins And Peptides Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.2. Germany Oral Proteins And Peptides Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.3. Germany Oral Proteins And Peptides Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Oral Proteins And Peptides Market

18.1. France Oral Proteins And Peptides Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.2. France Oral Proteins And Peptides Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.3. France Oral Proteins And Peptides Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Oral Proteins And Peptides Market

19.1. Italy Oral Proteins And Peptides Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.2. Italy Oral Proteins And Peptides Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.3. Italy Oral Proteins And Peptides Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Oral Proteins And Peptides Market

20.1. Spain Oral Proteins And Peptides Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.2. Spain Oral Proteins And Peptides Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.3. Spain Oral Proteins And Peptides Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Oral Proteins And Peptides Market

21.1. Eastern Europe Oral Proteins And Peptides Market Overview
21.2. Eastern Europe Oral Proteins And Peptides Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.3. Eastern Europe Oral Proteins And Peptides Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.4. Eastern Europe Oral Proteins And Peptides Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Oral Proteins And Peptides Market

22.1. Russia Oral Proteins And Peptides Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.2. Russia Oral Proteins And Peptides Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.3. Russia Oral Proteins And Peptides Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Oral Proteins And Peptides Market

23.1. North America Oral Proteins And Peptides Market Overview
23.2. North America Oral Proteins And Peptides Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.3. North America Oral Proteins And Peptides Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.4. North America Oral Proteins And Peptides Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Oral Proteins And Peptides Market

24.1. USA Oral Proteins And Peptides Market Overview
24.2. USA Oral Proteins And Peptides Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.3. USA Oral Proteins And Peptides Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.4. USA Oral Proteins And Peptides Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Oral Proteins And Peptides Market

25.1. Canada Oral Proteins And Peptides Market Overview
25.2. Canada Oral Proteins And Peptides Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.3. Canada Oral Proteins And Peptides Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.4. Canada Oral Proteins And Peptides Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Oral Proteins And Peptides Market

26.1. South America Oral Proteins And Peptides Market Overview
26.2. South America Oral Proteins And Peptides Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.3. South America Oral Proteins And Peptides Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.4. South America Oral Proteins And Peptides Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Oral Proteins And Peptides Market

27.1. Brazil Oral Proteins And Peptides Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.2. Brazil Oral Proteins And Peptides Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.3. Brazil Oral Proteins And Peptides Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Oral Proteins And Peptides Market

28.1. Middle East Oral Proteins And Peptides Market Overview
28.2. Middle East Oral Proteins And Peptides Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.3. Middle East Oral Proteins And Peptides Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.4. Middle East Oral Proteins And Peptides Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Oral Proteins And Peptides Market

29.1. Africa Oral Proteins And Peptides Market Overview
29.2. Africa Oral Proteins And Peptides Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.3. Africa Oral Proteins And Peptides Market, Segmentation By Mechanism Of Action, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.4. Africa Oral Proteins And Peptides Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Oral Proteins And Peptides Market Competitive Landscape And Company Profiles

30.1. Oral Proteins And Peptides Market Competitive Landscape
30.2. Oral Proteins And Peptides Market Company Profiles
- 30.2.1. Pfizer Inc.
  - 30.2.1.1. Overview
  - 30.2.1.2. Products and Services
  - 30.2.1.3. Strategy
  - 30.2.1.4. Financial Performance
- 30.2.2. Johnson & Johnson Services Inc.
  - 30.2.2.1. Overview
  - 30.2.2.2. Products and Services
  - 30.2.2.3. Strategy
  - 30.2.2.4. Financial Performance
- 30.2.3. Roche Holding AG
  - 30.2.3.1. Overview
  - 30.2.3.2. Products and Services
  - 30.2.3.3. Strategy
  - 30.2.3.4. Financial Performance
- 30.2.4. Merck & Co. Inc.
  - 30.2.4.1. Overview
  - 30.2.4.2. Products and Services
  - 30.2.4.3. Strategy
  - 30.2.4.4. Financial Performance
- 30.2.5. AbbVie Inc.
  - 30.2.5.1. Overview
  - 30.2.5.2. Products and Services
  - 30.2.5.3. Strategy
  - 30.2.5.4. Financial Performance

31. Oral Proteins And Peptides Market Other Major And Innovative Companies

31.1. Sanofi S.A.
31.2. AstraZeneca PLC
31.3. Novartis AG
31.4. GlaxoSmithKline PLC
31.5. Eli Lilly and Company
31.6. Amgen Inc.
31.7. Novo Nordisk A/S
31.8. Ipsen S.A.
31.9. Biocon Limited
31.10. Xeris Pharmaceuticals Inc.
31.11. Adocia S.A.
31.12. Zealand Pharma A/S
31.13. Diabetology Ltd.
31.14. Oramed Pharmaceuticals Inc.
31.15. Palatin Technologies Inc.

32. Global Oral Proteins And Peptides Market Competitive Benchmarking

33. Global Oral Proteins And Peptides Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Oral Proteins And Peptides Market

35. Oral Proteins And Peptides Market Future Outlook and Potential Analysis

35.1 Oral Proteins And Peptides Market In 2028 - Countries Offering Most New Opportunities
35.2 Oral Proteins And Peptides Market In 2028 - Segments Offering Most New Opportunities
35.3 Oral Proteins And Peptides Market In 2028 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer